Kura Oncology shares rose in premarket trading Friday after it said it has received a milestone payment of $30 million for the next stage of its cancer drug trial. Shares rose 7% ahead of the morning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback